
AstraZeneca's revenue by therapeutic area 2020-2022
This statistic shows the revenue of pharmaceutical company AstraZeneca by therapy area from 2020 to 2022. In 2022, revenue in the area of oncology amounted to 14.6 billion U.S. dollars. AstraZeneca plc is a leading pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.